NPI: 1962476606 · LAGUNA HILLS, CA 92653 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 02/16/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (SR DIR LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 02/16/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 10,303 | $594K |
| 2019 | 10,454 | $558K |
| 2020 | 12,356 | $588K |
| 2021 | 11,176 | $496K |
| 2022 | 10,821 | $483K |
| 2023 | 6,432 | $842K |
| 2024 | 2,735 | $709K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 26,577 | 2,080 | $3.77M |
| A4657 | Syringe, with or without needle, each | 583 | 527 | $286K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 945 | 438 | $103K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 18,429 | 1,324 | $44K |
| J1270 | Injection, doxercalciferol, 1 mcg | 11,248 | 926 | $37K |
| J1756 | Injection, iron sucrose, 1 mg | 3,752 | 1,054 | $15K |
| 0250 | 634 | 55 | $10K | |
| 90674 | 26 | 25 | $559.80 | |
| 90661 | 12 | 12 | $397.92 | |
| 90662 | 13 | 13 | $231.32 | |
| 83970 | 187 | 170 | $80.34 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 45 | 29 | $28.27 |
| 82728 | 137 | 124 | $27.66 | |
| 85041 | 461 | 416 | $8.79 | |
| 85045 | 121 | 105 | $8.24 | |
| 85048 | 402 | 363 | $2.94 | |
| 83540 | 121 | 110 | $0.00 | |
| 0634 | 264 | 17 | $0.00 | |
| 82108 | 14 | 14 | $0.00 | |
| 83550 | 107 | 96 | $0.00 | |
| 0636 | 199 | 14 | $0.00 |